ARCHIVES

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

Funding Opportunities listed.

May 21, 2004

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

CMS Unable to Adjust Cuts To Cancer Care

June 7, 2013